Compound
← Compound
Official website →
CVSCVS HEALTH Corp
Quotes delayed by up to 15 minutes · informational, not investment advice
Escopo e origem dos dados
- Ativo
- CVS
- Moeda das demonstrações
- USD
- Último período anual nesta tabela
- 2025-12-31
- Fonte das demonstrações
- SEC EDGAR
Data de demonstração não é horário de cotação. Dado ausente não é zero. A cobertura varia por ativo e fonte; confira o documento original antes de interpretar um número.
Fontes e metodologiaAbout the company
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider.…
IndustryMedical - Healthcare Plans
Smart calendar
Organizing upcoming events...
Key metrics
What the market pays
P/E
Price divided by trailing 12-month earnings
23.2×
P/B
Price divided by book value
1.42×
EV/EBITDA
Enterprise value divided by operating cash generation
13.3×
EV/Revenue
Enterprise value divided by revenue
0.43×
What the company earns
ROE
Return on shareholders’ equity
6.4%
ROA
Return on all assets
1.9%
Gross margin
What remains after product costs
14.2%
Operating margin
What remains after operating the business
2%
Net margin
How much of each revenue unit becomes profit
1.2%
What it owes
Debt / Equity
Debt for each unit of shareholders’ equity
0.96
Total debt
Sum of borrowings
$76.31B
Cash
Cash available to cover it
$11.33B
Current ratio
Short-term assets divided by short-term liabilities
0.87
Free cash flow
Cash left after investing
$5.65B
Risk and growth
Beta
Moves more (>1) or less (<1) than the market
0.58
Revenue growth
Compared with the same period a year earlier
7.3%
Earnings growth
Compared with the same period a year earlier
193.3%
Dividend yield
Trailing 12-month distributions divided by price
3%
Market data provider figures for the latest published period. Informational, not investment advice.
Financial statements(USD)
Income statement
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Receita | 322.47B | 357.78B | 372.81B | 402.07B |
| Custo dos produtos | -196.89B | -217.1B | -206.29B | -221.17B |
| Resultado operacional | 7.95B | 13.74B | 8.52B | 4.66B |
| Despesa financeira | -2.29B |
Follow CVS and get agent analysis of what is moving the stock.
Open Compound